Paper39808673
Naturally occurring variation in a cytochrome P450 modifies thiabendazole responses independently of beta-tubulin.
Collins JB and 13 others. PLoS Pathog, 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Naturally occurring variation in a cytochrome P450 modifies thiabendazole responses independently of beta-tubulin. Papers, record 39808673. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39808673
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Naturally occurring variation in a cytochrome P450 modifies thiabendazole responses independently of beta-tubulin.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Caenorhabditis elegans | Major topic |
| Cytochrome P-450 Enzyme System | Major topic |
| Tubulin | Major topic |
| Thiabendazole | Major topic |
| Caenorhabditis elegans Proteins | Major topic |
| Drug Resistance | Major topic |
| Anthelmintics | Major topic |
| Animals | |
| Quantitative Trait Loci | |
| Genome-Wide Association Study |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 AI153088 | NIAID NIH HHS | United States | R01AI153088 | PubMed and NIH |
Source NIH RePORTER
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33317926 | Complementary Approaches with Free-living and Parasitic Nematodes to Understanding Anthelmintic Resistance. | Trends Parasitol | 2021 | https://conductscience.org/library/papers/33317926 | PubMed |
| 2 | 29601575 | Discovery of genomic intervals that underlie nematode responses to benzimidazoles. | PLoS Negl Trop Dis | 2018 | https://conductscience.org/library/papers/29601575 | PubMed |
| 3 | 22669657 | Caenorhabditis elegans as a model in developmental toxicology. | Methods Mol Biol | 2012 | https://conductscience.org/library/papers/22669657 | PubMed |
| 4 | 37855690 | CaeNDR, the Caenorhabditis Natural Diversity Resource. | Nucleic Acids Res | 2024 | https://conductscience.org/library/papers/37855690 | PubMed |
| 5 | 39572328 | Integrating metabolomics into the diagnosis and investigation of anthelmintic resistance. | Trends Parasitol | 2024 | https://conductscience.org/library/papers/39572328 | PubMed |
| 6 | 30471287 | Deep amplicon sequencing as a powerful new tool to screen for sequence polymorphisms associated with anthelmintic resistance in parasitic nematode populations. | Int J Parasitol | 2019 | https://conductscience.org/library/papers/30471287 | PubMed |
| 7 | 32858477 | Quantitative benzimidazole resistance and fitness effects of parasitic nematode beta-tubulin alleles. | Int J Parasitol Drugs Drug Resist | 2020 | https://conductscience.org/library/papers/32858477 | PubMed |
| 8 | 32385045 | The Gene scb-1 Underlies Variation in Caenorhabditis elegans Chemotherapeutic Responses. | G3 (Bethesda) | 2020 | https://conductscience.org/library/papers/32385045 | PubMed |
| 9 | 2513255 | Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. | Genetics | 1989 | https://conductscience.org/library/papers/2513255 | PubMed |
| 10 | 15034147 | MUSCLE: multiple sequence alignment with high accuracy and high throughput. | Nucleic Acids Res | 2004 | https://conductscience.org/library/papers/15034147 | PubMed |
| 11 | 33720993 | Two novel loci underlie natural differences in Caenorhabditis elegans abamectin responses. | PLoS Pathog | 2021 | https://conductscience.org/library/papers/33720993 | PubMed |
| 12 | 8096381 | Effect of selection for benzimidazole resistance in Haemonchus contortus on beta-tubulin isotype 1 and isotype 2 genes. | Biochem Biophys Res Commun | 1993 | https://conductscience.org/library/papers/8096381 | PubMed |
| 13 | 25770127 | A Powerful New Quantitative Genetics Platform, Combining Caenorhabditis elegans High-Throughput Fitness Assays with a Large Collection of Recombinant Strains. | G3 (Bethesda) | 2015 | https://conductscience.org/library/papers/25770127 | PubMed |
| 14 | 28746337 | Genome-wide analysis of ivermectin response by Onchocerca volvulus reveals that genetic drift and soft selective sweeps contribute to loss of drug sensitivity. | PLoS Negl Trop Dis | 2017 | https://conductscience.org/library/papers/28746337 | PubMed |
| 15 | 32122383 | New codon 198 β-tubulin polymorphisms in highly benzimidazole resistant Haemonchus contortus from goats in three different states in Sudan. | Parasit Vectors | 2020 | https://conductscience.org/library/papers/32122383 | PubMed |
| 16 | 21468315 | Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus. | PLoS Negl Trop Dis | 2011 | https://conductscience.org/library/papers/21468315 | PubMed |
| 17 | 7911975 | Benzimidazole resistance in Haemonchus contortus is correlated with a conserved mutation at amino acid 200 in beta-tubulin isotype 1. | Mol Biochem Parasitol | 1994 | https://conductscience.org/library/papers/7911975 | PubMed |
| 18 | 39668355 | Differences in constitutive gene expression of cytochrome P450 enzymes and ATP-binding cassette transporter gene expression between a susceptible and a highly macrocyclic lactone-resistant Haemonchus contortus isolate in the absence of drug-inducible expression. | Parasit Vectors | 2024 | https://conductscience.org/library/papers/39668355 | PubMed |
| 19 | 34637983 | Newly identified parasitic nematode beta-tubulin alleles confer resistance to benzimidazoles. | Int J Parasitol Drugs Drug Resist | 2021 | https://conductscience.org/library/papers/34637983 | PubMed |
| 20 | 38956039 | Cyprocide selectively kills nematodes via cytochrome P450 bioactivation. | Nat Commun | 2024 | https://conductscience.org/library/papers/38956039 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42947444 | Synthetic Strategy to Novel Highly Functionalized Furan Analogues Bearing Imidazole-Thiazole Hybrids: Structural Characterization, Nanoparticle Formulations, Antimicrobial Evaluation, Molecular Docking Studies, and Molecular Dynamic Simulations. | Chem Biodivers | 2026 | https://conductscience.org/library/papers/42947444 | PubMed |
| 42766653 | The nematode Caenorhabditis elegans has a cationic amphiphilic drug (CAD) defense system. | PLoS Biol | 2026 | https://conductscience.org/library/papers/42766653 | PubMed |
| 42247472 | Evaluating beta-tubulin variants as predictors of benzimidazole resistance across Caenorhabditis nematodes. | PLoS Pathog | 2026 | https://conductscience.org/library/papers/42247472 | PubMed |
| 41928777 | Methods for single-pair Ascaridia galli genetic crosses. | MicroPubl Biol | 2026 | https://conductscience.org/library/papers/41928777 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39808673
GET https://conductscience.org/api/papers/v1/39808673/references?page=2